| Gene symbol | CCNG1 | Synonyms | CCNG | Type of gene | protein-coding |
| Chromosome | 5 | Map location | 5q34 | dbXrefs | |
| Description | cyclin G1 | ||||
| GTO ID | GTC1230 |
| Trial ID | NCT00121745 |
| Disease | Pancreatic Cancer |
| Altered gene | CCNG1 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | Rexin-G |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | Phase I Evaluation of Safety of Intravenous Infusion of a Pathotropic Vector Bearing a Cytocidal Cyclin G1 Construct (Rexin-G) as Intervention for Locally Advanced and Metastatic Pancreatic Cancer Refractory to Standard Chemotherapy |
| Year | 2005 |
| Country | United States |
| Company sponsor | Epeius Biotechnologies |
| Other ID(s) | MC044C |
| Vector information | |||
|
|||
| Cohort1: dose level 1 | |||||||
|
|||||||
| Cohort2: dose level 2 | |||||||
|
|||||||
| Cohort3: dose level 3 | |||||||
|
|||||||
| Cohort4: dose level 4 | |||||||
|
|||||||